All Stories

  1. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance

    Article • Leukemia & Lymphoma, September 2018, Taylor & Francis

    Dr Marco Herling

  2. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

    Article • European Journal Of Haematology, May 2017, Wiley

    Dr Marco Herling

  3. AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1

    Article • Current Cancer Drug Targets, November 2014, Bentham Science Publishers

    Dr Marco Herling